Company Description
Chimera Investment Corporation operates as a real estate investment trust (REIT) in the United States.
The company, through its subsidiaries, invests in a portfolio of mortgage assets, including residential mortgage loans, agency residential mortgage-backed securities, non-agency residential mortgage-backed securities, agency mortgage-backed securities secured by pools of commercial mortgage loans, business purpose and investor loans, and other real estate related securities.
It invests in investment grade, non-investment grade, and non-rated classes. The company qualifies as a real estate investment trust (REIT) for federal income tax purposes.
As a REIT, it intends to distribute at least 90% of its taxable income as dividends to shareholders. Chimera Investment Corporation was incorporated in 2007 and is headquartered in New York, New York.
Country | United States |
Founded | 2007 |
IPO Date | Nov 16, 2007 |
Industry | REIT - Mortgage |
Sector | Real Estate |
Employees | 39 |
CEO | Phillip John Kardis II, Esq., J.D. |
Contact Details
Address: 520 Madison Avenue, 32nd Floor New York, New York 10022 United States | |
Phone | 212-626-2300 |
Website | chimerareit.com |
Stock Details
Ticker Symbol | CIM |
Exchange | NYSE |
Fiscal Year | January - December |
Reporting Currency | USD |
CIK Code | 0001409493 |
CUSIP Number | 16934Q208 |
ISIN Number | US16934Q2084 |
Employer ID | 26-0630461 |
SIC Code | 6798 |
Key Executives
Name | Position |
---|---|
Phillip John Kardis II, Esq. | President, Chief Executive Officer and Director |
Subramaniam Viswanathan | Chief Financial Officer and Principal Accounting Officer |
Dan Thakkar | Chief Investment Officer |
Emily Mohr | Investor Relations Officer |
Miyun Sung J.D. | Chief Legal Officer and Secretary |
Victor Falvo | Head of Capital Markets |
Latest SEC Filings
Date | Type | Title |
---|---|---|
May 10, 2024 | 8-K | Current Report |
May 9, 2024 | 10-Q | Quarterly Report |
May 9, 2024 | 8-K | Current Report |
May 9, 2024 | 8-K | Current Report |
Apr 22, 2024 | ARS | Filing |
Apr 22, 2024 | DEFA14A | Additional definitive proxy soliciting materials and Rule 14(a)(12) material |
Apr 22, 2024 | DEF 14A | Other definitive proxy statements |
Mar 28, 2024 | 8-K | Current Report |
Mar 19, 2024 | 8-K | Current Report |
Feb 29, 2024 | 10-K | Annual Report |